Argentina Medical Device Penalty Regime: Preventive Measures to Criminal Liability

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Argentina’s penalty regime is structured in 3 tiers:

  1. Preventive measures (Decreto 341/92), which can be applied before an investigation concludes, including sales bans, market withdrawal, and suspension of registration;
  2. Administrative penalties (Ley 16.463, with Ley 18.284 cited in some circumstances), namely fines, suspension, and cancellation of registration, subject to the corresponding procedures;
  3. Criminal and civil liability (Ley 16.463; for false declarations, Article 110 of Decreto 1759/72): where the content of a sworn declaration is untrue, false, or contains material omissions, administrative and even criminal liability may be pursued.

With the 2025–2026 reforms converting the front end to a sworn declaration system, the weight of responsibility at the signing stage has risen sharply: the simpler the procedure, the heavier the signer’s liability. The state trades ex-ante review for a personal legal commitment, and it enforces that commitment through all three tiers at once.

For planning purposes, the three tiers should be read as one escalating system rather than three separate regimes. A preventive measure is not a finding of guilt, but it produces the commercial effect of one while the case runs; an administrative penalty follows the procedure of Decreto 341/92 and the substantive law cited in each instrument; and the criminal tier attaches to personal conduct, above all the truthfulness of sworn declarations. The same underlying facts can travel through all three tiers, which is why the response to any notice must be coordinated legally, commercially, and technically from the first hour.

2. Legal basis

RegulationReference / numberPublication dateProvisions
National health products lawLey 16.463Enacted 1964; in forceAdministrative penalty and criminal liability provisions
Argentine Food Code (cited for penalties)Ley 18.284In forcePenalty citation provisions
Procedures for administrative penalties and preventive measuresDecreto 341/921992Preventive measures provisions
Administrative procedures lawDecreto 1759/721972Article 110 (untrue sworn declarations)
Simplified company qualification pathway for low-risk entitiesDisposición ANMAT 8799/2025Published November 28, 2025; effective 60 administrative working days after publicationPenalty provisions for untrue declarations
Notification regime for low and medium-risk productsDisposición ANMAT 236/2026Published February 6, 2026; effective 30 days after publicationPenalty provisions for violations

3. Expert insights

Insight 1: Preventive measures are the tier most in need of a contingency plan. They can be implemented before an investigation reaches its conclusion, which means a single reported suspected violation can result in products being pulled from the market immediately. A company without an emergency plan will be passive precisely during the period that most demands rapid response: sales frozen, customers asking questions, and a formal case running in parallel. The plan must exist before the notice arrives, because the value of preparation lies entirely in the speed of the first 48 hours after a preventive measure is served.

Insight 2: Both 8799/2025 and 236/2026 point penalties at existing law rather than creating new sanction regimes. Both new instruments expressly provide that violations are handled under existing laws such as Ley 16.463. The legislators’ intent is clear: relax ex-ante access, but retain the original penalty intensity. This confirms the judgment that simplification is not relaxation. Companies reading the new instruments as a lighter-touch era misread them; the state has moved its scrutiny from the submission desk to the market and the inspection file, where the consequences are harder to manage and more public.

Insight 3: Liability for untrue declarations attaches to the signer personally. Article 110 of Decreto 1759/72 targets the truthfulness of sworn declarations. In Argentina, registration documents must be signed jointly by the legal representative and the technical director, and both bear personal responsibility for the truthfulness of the documents. The technical director is not a formal or ceremonial position, and this point is routinely underestimated. Foreign manufacturers appointing or relying on a local technical director should understand that this individual carries personal legal exposure for the accuracy of every filed statement.

Insight 4: The reforms’ reliance on existing penalty law has a practical consequence for documentation. Because violations are assessed under Ley 16.463 and the procedural framework of Decreto 341/92, the evidence that matters is the same evidence a company would need in any mature market: dated records of decisions, verifiable claims behind declarations, and demonstrable control over promotional and technical content. The simplification of the front end does not lower this evidentiary bar; it raises its importance, because with fewer ex-ante checks there are fewer opportunities to correct issues before they become findings. Companies transitioning to the sworn declaration model should audit their existing records against this standard before filing, since the first declaration signed under the new regime is also the first artifact an inspector will examine.

4. Practical recommendations

  1. Prepare an emergency plan for preventive measures. Define, upon receiving a sales ban or suspension notice, who handles the market withdrawal, who communicates with customers, and who prepares the appeal materials, all launchable within 48 hours.
  2. Establish a fact-checking process before signing. For every document requiring a sworn declaration, complete a factual verification before signature and archive it; the verification record is stored together with the declaration.
  3. Formally authorize and train the technical director role. Define the scope of signing responsibility, and provide the role with the regulatory training and access to information it needs.
  4. Create an internal escalation channel for violation leads. Set up a direct reporting path from sales, quality, and customer service to the regulatory function, so that problems are not suppressed within commercial units.

5. Verification checklist

  • □ An emergency plan for sales ban and suspension notices has been prepared, launchable within 48 hours
  • □ A fact-checking and archiving process before signing sworn declarations has been established
  • □ The technical director has completed authorization and regulatory training
  • □ The circumstances of application of Article 110 of Decreto 1759/72 have been clarified
  • □ A direct internal escalation channel for violation leads has been established
  • □ It has been understood that 8799/2025 and 236/2026 cite existing law rather than creating new penalty regimes

Regulatory information verified as of October 29, 2026.

In Argentina, GRZAN operates a wholly owned subsidiary that can act as the registration holder and importer for foreign manufacturers, directly handling classification assessment, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.

The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience, tracking the developments of regulators worldwide. All external content follows the drafting standard of conclusions first, traceable basis, and verifiable numbers. For a market access plan tailored to your specific product for Argentina or the MERCOSUR region, contact the GRZAN regulatory team at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail